USLM vs UTMD โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
UTMD Captures Institutional Edge (2โ2 Pillars ยท 5โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Utah Medical Products Inc (UTMD) driven by superior Valuation, Momentum & Technical while USLM counters with relative strength in Growth & Margin, Options & Structure. Fundamentally, USLM trades at 18.5x Forward P/E with 41.2% operating margin (+4.1% YoY revenue) versus UTMD at 13.0x Forward P/E and 34.3% operating margin (-12.1% YoY). In options structure, USLM sits in CONSOLIDATION (7th %ile IV; Dealer Gamma Walls on Pro) against UTMD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | USLM | UTMD | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $3.3B | $209.6M | Larger Scale | USLM |
| Trailing P/E Ratio Valuation | 24.6x | 22.0x | Lower Multiple | UTMD |
| Forward P/E Ratio Valuation | 18.5x | 13.0x | Lower Multiple | UTMD |
| Revenue Growth (YoY) Growth | +4.1% | -12.1% | Higher Growth | USLM |
| Operating Margin (TTM) Profitability | 41.2% | 34.3% | Higher Margin | USLM |
| Net Profit Margin Profitability | 35.1% | 30.5% | Higher Margin | USLM |
| Return on Equity (ROE) Capital Efficiency | 20.0% | 8.8% | Higher ROE | USLM |
| 52-Week Range Position Momentum | 24% ($96โ$141) | 81% ($54โ$77) | Stronger Trend | UTMD |
| Beta / 30D Volatility Risk Regime | 0.74ฮฒ ยท 42% Vol | 0.23ฮฒ ยท 33% Vol | Lower Realized Risk | UTMD |
| Unified Institutional Score Composite Signal | 46.1 / 100 (HOLD) | 52.9 / 100 (HOLD) | Higher Composite | UTMD |